Evidence map›Paper›PMID 40932734›Full record

ArticleJAMA otolaryngology-- head & neck surgery2025

Barriers and Timely Postoperative Radiation Therapy in Head and Neck Cancer.

Megan T Nguyen, Emily Kistner-Griffin, Reid DeMass, Bhisham S Chera, Chanita Hughes Halbert, Katherine R Sterba, Elizabeth G Hill, Brian Nussenbaum, Anthony J Alberg, Vlad C Sandulache and 8 more

Abstract read
In one paragraph

Article in JAMA otolaryngology-- head & neck surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Megan T NguyenDepartment of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston.
Emily Kistner-GriffinDepartment of Public Health Sciences, Medical University of South Carolina, Charleston.
Reid DeMassDepartment of Public Health Sciences, Medical University of South Carolina, Charleston.
Bhisham S CheraHollings Cancer Center, Medical University of South Carolina, Charleston.
Chanita Hughes HalbertDepartment of Population and Public Health Sciences, University of Southern California, Los Angeles.
Katherine R SterbaDepartment of Public Health Sciences, Medical University of South Carolina, Charleston.
Elizabeth G HillDepartment of Public Health Sciences, Medical University of South Carolina, Charleston.
Brian NussenbaumAmerican Board of Otolaryngology-Head and Neck Surgery, Houston, Texas.
Anthony J AlbergDepartment of Epidemiology and Biostatistics, University of South Carolina Arnold School of Public Health, Columbia.
Vlad C SandulacheBobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas.
David J HernandezBobby R. Alford Department of Otolaryngology-Head and Neck Surgery, Baylor College of Medicine, Houston, Texas.
Ryan S JacksonDepartment of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St Louis, Missouri.
Sidharth V PuramDepartment of Otolaryngology-Head and Neck Surgery, Washington University School of Medicine, St Louis, Missouri.
Russel KahmkeDepartment of Head and Neck Surgery and Communication Sciences, Duke University, Durham, North Carolina.
Nosayaba Osazuwa-PetersDepartment of Head and Neck Surgery and Communication Sciences, Duke University, Durham, North Carolina.
Gail JacksonHead and Neck Cancer Alliance, Charleston, South Carolina.
Sue S YomDepartment of Radiation Oncology, University of California, San Francisco.
Evan M GraboyesDepartment of Otolaryngology-Head and Neck Surgery, Medical University of South Carolina, Charleston.

Funding

Translational Science Laboratory Shared ResourceP30CA138313 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI RAYMOND N. DUBOIS · 2009 to 2026
$42.7M
South Carolina Clinical & Translational Research Institute (SCTR)UL1TR000062 · NCATS · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BRADY, KATHLEEN T. · 2012 to 2014
$9.4M
A Type I Hybrid Effectiveness-Implementation Trial to Evaluate a Navigation-Based Multilevel Intervention to Decrease Delays Starting Adjuvant Therapy Among Patients with Head and Neck CancerR01CA282165 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI Evan Michael Graboyes · 2023 to 2026
$2.8M
Improving the Timeliness and Equity of Adjuvant Therapy Following Surgery for Head and Neck CancerK08CA237858 · NCI · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI GRABOYES, EVAN MICHAEL · 2019 to 2023
$1.3M
NCATS NIH HHS UL1 TR000062NCI NIH HHS K08 CA237858NCI NIH HHS P30 CA138313NCI NIH HHS R01 CA282165
6 · The paper itself

Abstract

Importance: Initiation of postoperative radiation therapy (PORT) within 6 weeks of surgery is associated with improved outcomes among patients with head and neck squamous cell carcinoma. However, the relationship of barriers to care with timely PORT is unknown. Objective: To categorize barriers to timely PORT, evaluate the association of barriers to care with initiation of timely PORT, and describe the primary reason for delay among patients without timely PORT. Design, Setting, and Participants: This prospective cohort study at a US academic medical center included adults with head and neck squamous cell carcinoma undergoing curative-intent surgery with an indication for PORT. Patients were recruited for the study from May 19, 2020, to November 6, 2023. Main Outcomes and Measures: The primary outcome was initiation of timely PORT, defined as starting radiation therapy within 6 weeks of surgery. Barriers to PORT were prospectively collected via patient self-report and the electronic health record. Among patients who did not start PORT within 6 weeks of surgery, the primary reason for delay was defined as the singular barrier category that most directly led to the delay. Results: Among 78 patients (mean [SD] age, 61.5 [10.8] years; 54 males [69.2%]), 32 patients (41%) initiated PORT within 6 weeks of surgery, and 46 patients (59%) did not initiate PORT within 6 weeks of surgery. Each additional barrier was associated with a decreased odds of initiating timely PORT (adjusted odds ratio, 0.81 [95% CI, 0.63-1.01]); patients with 5 or more barriers had a 76% reduction in the odds of starting PORT within 6 weeks of surgery relative to those with 0 to 2 barriers (adjusted odds ratio, 0.24 [95 CI%, 0.06-0.84]) on multivariable analysis. When analyzed by barrier category, patients with a perioperative adverse effects-related barrier were less likely to initiate timely PORT than patients without a perioperative adverse effects barrier (adjusted odds ratio, 0.17 [95% CI, 0.04-0.66]) on multivariable analysis. Among patients without timely PORT, the most common primary reason for delay was a barrier related to poor care coordination (19/46 [41.3%]). Conclusions and Relevance: In this prospective cohort study, patients with a greater number of barriers and those with a barrier related to the perioperative adverse effects category were less likely to initiate timely PORT. Among patients without timely PORT, the most common primary reason for delay was a barrier related to poor care coordination. Efforts to improve timely PORT should focus on decreasing the number of barriers, improving surgical quality, and enhancing care coordination.

Indexed as

Head and Neck NeoplasmsHealth Services AccessibilityPostoperative CareSquamous Cell Carcinoma of Head and NeckTime-to-TreatmentAgedFemaleHumansMaleMiddle AgedProspective StudiesRadiotherapy, AdjuvantTime Factors

Identifiers

PMID40932734
PMCPMC12426859

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.